Table 2 Transplant surgery and years since transplant in the study (n = 93) and lung transplant recipients with/without PRA (n = 23 vs 70, respectively)
From: The fraction of sensitization among lung transplant recipients in a transplant center in Japan
Total (n = 93) | PRA+ (n = 23) | PRA- (n = 70) | p-value | |
|---|---|---|---|---|
CMV mismatch (D+/R-)a | 16 (17.2%) | 1 (4.3%) | 15 (21.4%) | 0.058 |
Donor age$ | 0.110 | |||
≤ 19 | 9 (9.7%) | 0 (0%) | 9 (12.9%) | |
20–59 | 79 (84.9%) | 20 (87.0%) | 59 (84.3%) | |
≥ 60 | 4 (4.3%) | 2 (8.7%) | 2 (2.9%) | |
Operative time (min) | 0.868 | |||
≤ 419 | 24 (25.8%) | 5 (21.7%) | 19 (27.1%) | |
420–839 | 47 (50.5%) | 12 (52.2%) | 35 (50.0%) | |
≥ 840 | 22 (23.7%) | 6 (26.1%) | 16 (22.9%) | |
Ischemic time (min)b | 0.861 | |||
≤ 419 | 21 (22.6%) | 5 (21.7%) | 16 (22.9%) | |
420–599 | 42 (45.2%) | 9 (39.1%) | 33 (47.1%) | |
≥ 600 | 29 (31.2%) | 8 (34.8%) | 21 (30.0%) | |
Yeas since transplant | 0.048 | |||
≤ 5 years | 40 (43.0%) | 14 (60.9%) | 26 (37.1%) | |
5–10 years | 36 (38.7%) | 4 (17.4%) | 32 (45.7%) | |
≥ 10 years | 17 (18.3%) | 5 (21.7%) | 12 (17.1%) |